Related Experiment Video
Updated: Jun 29, 2026

09:03
The CYP2D6 Animal Model: How to Induce Autoimmune Hepatitis in Mice
Published on: February 3, 2012
19.5K
A Devastating Case of Hepatitis C-Induced Mixed Cryoglobulinemia
Sameeha Khalid1, Dhuha Alhankawi2, Kamalmeet Kaur1
1Department of Internal Medicine, University of California San Francisco-Fresno, Fresno, CA, USA.
Case Reports in Hepatology
|October 18, 2021
Summary
Hepatitis C virus (HCV) can cause rare, severe mixed cryoglobulinemia leading to limb gangrene. Early direct-acting antiviral therapy for HCV is crucial to prevent and halt this devastating vasculitis progression.
Area of Science:
- Hepatology
- Immunology
- Vascular Medicine
Background:
- Hepatitis C virus (HCV) infection is a significant cause of chronic liver disease worldwide.
- Mixed cryoglobulinemia is a rare immune complex-mediated vasculitis associated with chronic HCV infection.
- This condition can lead to severe systemic complications, including critical limb ischemia.
Observation:
- A 55-year-old male with untreated chronic HCV presented with arthralgia and palpable purpura.
- The patient rapidly developed severe, life-threatening gangrene affecting all extremities.
- This critical presentation necessitated multiple amputations due to mixed cryoglobulinemia.
Findings:
- Initiation of treatment for chronic hepatitis C virus infection led to the cessation of gangrene progression.
- The patient's survival was achieved through timely antiviral therapy targeting the underlying HCV infection.
- Mixed cryoglobulinemia associated with HCV can manifest as rapidly progressive, severe peripheral gangrene.
Implications:
- Early diagnosis and treatment of HCV are vital to prevent severe vasculitic complications like gangrene.
- Direct-acting antiviral (DAA) therapy should be considered promptly in patients with HCV-associated cryoglobulinemia.
- Universal screening for HCV may facilitate earlier detection and intervention, averting catastrophic outcomes such as limb loss.
Related Concept Videos
Hypersensitivity Reactions: Cytolytic Reactions
Type II hypersensitivity involves IgG and IgM antibodies targeting cell surface antigens, leading to cell destruction. This can occur through complement activation, antibody-dependent cell-mediated cytotoxicity (ADCC), or acting as opsonins for phagocytosis. When excessive, these reactions cause significant tissue damage.Drug-induced hemolytic anemia is a common example, where drugs like penicillin or cephalosporins bind to red blood cells, forming drug-protein complexes. These complexes...
Cytomegalovirus Disease
Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
Hepatitis
Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Viral Hepatitis I: Introduction
Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
Cirrhosis I: Introduction
Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
Cirrhosis II: Pathophysiology
Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...

